search Created with Sketch.
search Created with Sketch.

Advertisement

MATV News: Positive Phase 4 Data for Kysse; Cutera Launches Fraxis Pro; Qwo Approved for Cellulite

July 17, 2020

Phase 4 study finds patients and partners satisfied with Restylane Kysse treatment; Cutera’s new Fraxis Pro combines fractional CO2 and RF microneedling; and FDA approves Endo’s Qwo as first injectable to target cellulite. Plus, could the recent uptick in Zoom calls be leading to a facial plastic surgery boom? 

Advertisement

In This Series

View More

Advertisement

Advertisement